Avadel Pharmaceuticals Ownership | Who Owns Avadel Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Avadel Pharmaceuticals Ownership Summary


Avadel Pharmaceuticals is owned by 83.40% institutional investors, 4.89% insiders, and 11.72% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.04% of AVDL shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.81% of its assets in Avadel Pharmaceuticals shares.

AVDL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAvadel Pharmaceuticals83.40%4.89%11.72%
SectorHealthcare Stocks 488.30%11.08%-399.38%
IndustrySpecialty & Generic Drug Manufacturers Stocks43.51%11.55%44.95%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.80M7.04%$60.21M
Brandes investment partners, lp6.49M6.72%$57.42M
Two seas capital lp6.16M6.37%$54.47M
Gendell jeffrey l5.18M5.36%$45.81M
Polar capital4.00M4.14%$35.39M
Vivo capital2.68M2.78%$23.75M
Wealth effects2.35M2.44%$20.84M
Tang capital management2.10M2.17%$18.56M
Kennedy capital management981.27K1.02%$8.68M
Krensavage asset management958.88K0.99%$8.49M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Wealth effects2.35M7.80%$20.84M
Knoll capital management600.00K5.68%$8.44M
Krensavage asset management958.88K4.49%$8.49M
Vivo capital2.68M2.43%$23.75M
Knott david m jr426.00K1.71%$3.77M
Samsara biocapital675.50K1.22%$5.98M
Gendell jeffrey l5.18M1.22%$45.81M
Tang capital management2.10M0.94%$18.56M
Two seas capital lp6.16M0.91%$54.47M
Iridian asset management llc/ct249.59K0.77%$2.21M

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de6.80M0.00%1.35M
Two seas capital lp6.16M0.91%1.21M
Brandes investment partners, lp6.49M0.52%820.47K
Invenomic capital management lp802.99K0.40%574.97K
Awm investment company316.19K0.31%275.19K

Top Sellers

HolderShares% AssetsChange
Janus henderson group---12.92M
Rtw investments, lp---8.80M
Braidwell lp---4.11M
Tri locum partners lp---1.94M
Adage capital partners gp---1.91M

New Positions

HolderShares% AssetsChangeValue
Jump financial138.95K0.01%138.95K$1.23M
Qube research119.96K0.00%119.96K$1.06M
Y-intercept (hong kong)95.85K0.02%95.85K$848.27K
Los angeles capital management79.11K0.00%79.11K$700.16K
Summit financial69.23K0.01%69.23K$612.70K

Sold Out

HolderChange
Principal securities-9.00
Zurcher kantonalbank (zurich cantonalbank)-19.00
Signaturefd-22.00
Stephens consulting-45.00
Fortitude family office-55.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025173-6.99%80,562,7284.59%831.31%92-7.07%48-2.04%
Mar 31, 20251855.71%77,012,100-3.02%791.17%9911.24%486.67%
Dec 31, 20242-60.00%137,001-87.20%-11.52%----100.00%
Sep 30, 20245-50.00%1,070,001-84.77%11.89%--100.00%1-
Jun 30, 202410-92.42%7,025,014-89.75%70.10%3-96.05%1-96.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Polar Capital Healthcare Opports Inc3.69M3.81%-
Vanguard US Total Market Shares ETF2.99M3.09%-
Vanguard Total Stock Mkt Idx Inv2.87M2.97%-63.75K
Janus Henderson Global Life Sciences D2.27M2.35%-178.86K
Janus Henderson Global Life Sciences2.27M2.35%-207.97K
iShares Russell 2000 ETF2.15M2.21%-
Janus Global Life Science AUSD1.89M1.95%-131.51K
Janus Henderson Glb Life Scn I2 USD1.72M1.78%-159.56K
Polar Capital Biotech S Inc1.50M1.56%-
Janus Henderson US Small Cap Growth MA1.48M1.54%1.48M

Recent Insider Transactions


DateNameRoleActivityValue
Jan 21, 2025Palczuk Linda-Buy$39.64K
Jan 13, 2025Thornton Peter J.-Buy$80.45K
Jan 13, 2025Ende Eric J-Buy$235.22K
Dec 13, 2024MCHUGH THOMAS S Chief Financial OfficerBuy$24.02K
Dec 11, 2024MCHUGH THOMAS S Chief Financial OfficerBuy$52.43K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q13-
2024 Q47-
2024 Q3--

AVDL Ownership FAQ


Who Owns Avadel Pharmaceuticals?

Avadel Pharmaceuticals shareholders are primarily institutional investors at 83.40%, followed by 4.89% insiders and 11.71% retail investors. The average institutional ownership in Avadel Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 43.51%, which Avadel Pharmaceuticals exceeds.

Who owns the most shares of Avadel Pharmaceuticals?

Avadel Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (6.8M shares, 7.04%), Brandes investment partners, lp (6.49M shares, 6.72%), and Two seas capital lp (6.16M shares, 6.37%). Together, they hold 20.13% of Avadel Pharmaceuticals’s total shares outstanding.

Does Blackrock own Avadel Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Avadel Pharmaceuticals.

Who is Avadel Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Wealth effects is Avadel Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 7.80% of its assets in 2.35M Avadel Pharmaceuticals shares, valued at 20.84M$.

Who is the top mutual fund holder of Avadel Pharmaceuticals shares?

Polar Capital Healthcare Opports Inc is the top mutual fund holder of Avadel Pharmaceuticals shares, with 3.81% of its total shares outstanding invested in 3.69M Avadel Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools